TASKAYNATAN, H.; KUCUKZEYBEK, Y.; YILDIZ, Y.; SALMAN, T.; OFLAZOGLU, U.; VAROL, U.; ALACACIOGLU, A.; SARAY, S.; OZDEMIR, O.; OKTAY TARHAN, M. Low dose (d1-5/7) oral etoposide regimen in intensively treated platinum-resistant epithelial ovarian cancer: The İzmir oncology group (IZOG) study . Annals of Medical Research, [S. l.], v. 27, n. 1, p. 0029–0033, 2021. Disponível em: http://www.annalsmedres.org/index.php/aomr/article/view/591. Acesso em: 18 may. 2024.